SUBCUTANEOUS OUTPATIENT MANAGEMENT
First Claim
1. A method comprising:
- receiving, at data processing hardware, subcutaneous information for a patient;
executing, at the data processing hardware, a subcutaneous outpatient program for determining recommended insulin dosages, the subcutaneous outpatient program comprising;
obtaining, at the data processing hardware, blood glucose data of the patient from a glucometer in communication with the computing device, the blood glucose data including blood glucose measurements of the patient, blood glucose times associated with the blood glucose measurements, and insulin dosages administered by the patient and associated with the blood glucose measurements;
determining, by the data processing hardware, scheduled blood glucose time intervals associated with the blood glucose measurements based on the blood glucose times;
aggregating, by the data processing hardware, the blood glucose measurements associated with at least one of the scheduled blood glucose time intervals to determine a representative aggregate blood glucose measurement associated with the at least one scheduled blood glucose time interval;
determining, by the data processing hardware, a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information; and
transmitting the next recommended insulin dosage from the data processing hardware to a portable device associated with the patient, the portable device displaying the next recommended insulin dosage.
4 Assignments
0 Petitions
Accused Products
Abstract
A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining blood glucose data of the patient from a glucometer in communication with the computing device, aggregating blood glucose measurements to determine a representative aggregate blood glucose measurement associated with at least one scheduled blood glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to a portable device associated with the patient. The portable device displays the next recommended insulin dosage.
37 Citations
30 Claims
-
1. A method comprising:
-
receiving, at data processing hardware, subcutaneous information for a patient; executing, at the data processing hardware, a subcutaneous outpatient program for determining recommended insulin dosages, the subcutaneous outpatient program comprising; obtaining, at the data processing hardware, blood glucose data of the patient from a glucometer in communication with the computing device, the blood glucose data including blood glucose measurements of the patient, blood glucose times associated with the blood glucose measurements, and insulin dosages administered by the patient and associated with the blood glucose measurements; determining, by the data processing hardware, scheduled blood glucose time intervals associated with the blood glucose measurements based on the blood glucose times; aggregating, by the data processing hardware, the blood glucose measurements associated with at least one of the scheduled blood glucose time intervals to determine a representative aggregate blood glucose measurement associated with the at least one scheduled blood glucose time interval; determining, by the data processing hardware, a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information; and transmitting the next recommended insulin dosage from the data processing hardware to a portable device associated with the patient, the portable device displaying the next recommended insulin dosage. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
-
16. A dosing controller comprising:
-
data processing hardware; and memory hardware in communication with the data processing hardware, the memory hardware storing instructions for a subcutaneous outpatient program that when executed on the data processing hardware cause the data processing hardware to perform operations comprising; receiving subcutaneous information for a patient; obtaining blood glucose data of the patient from a glucometer in communication with the data processing hardware, the blood glucose data including blood glucose measurements of the patient, blood glucose times associated with the blood glucose measurements, and insulin dosages administered by the patient and associated with the blood glucose measurements; determining scheduled blood glucose time intervals associated with the blood glucose measurements based on the blood glucose times; aggregating the blood glucose measurements associated with at least one of the scheduled blood glucose time intervals to determine a representative aggregate blood glucose measurement associated with the at least one scheduled blood glucose time interval; determining a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information; and transmitting the next recommended insulin dosage to a portable device associated with the patient, the portable device displaying the next recommended insulin dosage. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)
-
Specification